These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1580270)

  • 21. Effect of quinolones on caffeine disposition.
    Carbó M; Segura J; De la Torre R; Badenas JM; Camí J
    Clin Pharmacol Ther; 1989 Mar; 45(3):234-40. PubMed ID: 2920498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
    Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
    Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
    Polk RE
    Am J Med; 1989 Nov; 87(5A):76S-81S. PubMed ID: 2686430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between the fluoroquinolones and the bronchodilator theophylline.
    Wijnands WJ; Vree TB
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():109-14. PubMed ID: 3053575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic interactions between theophylline and other medication (Part I).
    Upton RA
    Clin Pharmacokinet; 1991 Jan; 20(1):66-80. PubMed ID: 1674242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones.
    Fuhr U; Doehmer J; Battula N; Wölfel C; Flick I; Kudla C; Keita Y; Staib AH
    Toxicology; 1993 Oct; 82(1-3):169-89. PubMed ID: 8236273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of new quinolone antimicrobial agents and macrolide antibiotics on the clearance of theophylline].
    Honma M
    Nihon Rinsho; 1996 Nov; 54(11):3125-9. PubMed ID: 8950966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
    Campbell ME; Grant DM; Inaba T; Kalow W
    Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug interactions with fluoroquinolones.
    Stein GE
    Am J Med; 1991 Dec; 91(6A):81S-86S. PubMed ID: 1767807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.
    Radandt JM; Marchbanks CR; Dudley MN
    Clin Infect Dis; 1992 Jan; 14(1):272-84. PubMed ID: 1571442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.
    Mizuki Y; Fujiwara I; Yamaguchi T
    J Antimicrob Chemother; 1996 May; 37 Suppl A():41-55. PubMed ID: 8737124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic interactions between fluoroquinolones and methylxanthines].
    Iakovlev VP; Iakovlev SV
    Antibiot Khimioter; 1999; 44(3):35-41. PubMed ID: 10382036
    [No Abstract]   [Full Text] [Related]  

  • 33. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interactions with quinolone antibacterials.
    Brouwers JR
    Drug Saf; 1992; 7(4):268-81. PubMed ID: 1524699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions with quinolones.
    Janknegt R
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():7-29. PubMed ID: 2286594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective in-vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorufin and caffeine as model substrates.
    Valero F; de la Torre R; Segura J
    J Pharm Pharmacol; 1991 Jan; 43(1):17-21. PubMed ID: 1676053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations.
    Machnik M; Kaiser S; Koppe S; Kietzmann M; Schenk I; Düe M; Thevis M; Schänzer W; Toutain PL
    Drug Test Anal; 2017 Sep; 9(9):1372-1384. PubMed ID: 27662634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes.
    Davis JD; Aarons L; Houston JB
    Xenobiotica; 1995 Jun; 25(6):563-73. PubMed ID: 7483657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.
    Sörgel F; Mahr G; Granneman GR; Stephan U; Nickel P; Muth P
    Clin Pharmacokinet; 1992; 22 Suppl 1():65-74. PubMed ID: 1319873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.